Introduction

Tropical pyomyositis is a primary bacterial infection of skeletal muscle characterized by localized pyogenic inflammation, intramuscular abscess formation, and progressive muscle necrosis. Unlike most skeletal muscle infections, tropical pyomyositis occurs without an obvious penetrating injury or contiguous spread from adjacent tissues. The disease is most common in tropical and subtropical regions and predominantly affects healthy children and young adults, although it occurs more frequently and is often more severe in individuals with immunocompromising conditions.

Staphylococcus aureus is responsible for approximately 70–90% of cases worldwide. Other causative organisms include streptococci, Gram-negative bacteria, and, less commonly, anaerobic organisms. Prompt recognition and treatment are essential to prevent abscess formation, sepsis, compartment syndrome, and permanent muscle dysfunction.

Epidemiology

• Common in tropical and subtropical regions.

• More frequent in children, adolescents, and young adults.

• Slight male predominance.

• More common among immunocompromised individuals.

• Increased incidence in patients with HIV infection, diabetes mellitus, malignancy, chronic kidney disease, malnutrition, and prolonged corticosteroid therapy.

• Lower limbs are affected in approximately two-thirds of cases.

Etiology

The exact mechanism responsible for tropical pyomyositis remains incompletely understood. Skeletal muscle is normally highly resistant to bacterial infection; however, transient bacteraemia combined with minor muscle injury or impaired host immunity allows bacterial invasion and proliferation.

Common causative organisms

• Staphylococcus aureus (most common)

• Group A Streptococcus

• Streptococcus species

• Gram-negative bacilli

• Anaerobic bacteria (uncommon)

In immunocompromised patients:

• Methicillin-resistant Staphylococcus aureus (MRSA)

• Fungal pathogens (rare)

Classification

According to disease stage

Stage I (invasive stage)

Diffuse muscle inflammation without abscess formation.

Stage II (suppurative stage)

Formation of one or more intramuscular abscesses.

Stage III (late or septic stage)

Extensive muscle destruction accompanied by systemic toxicity, septicemia, or multi-organ dysfunction.

Pathophysiology

Tropical pyomyositis usually begins with transient bacteraemia, most commonly caused by Staphylococcus aureus. Under normal circumstances, skeletal muscle is highly resistant to bacterial invasion because of its rich blood supply, high oxygen tension, and effective host immune defences. However, minor muscle trauma, vigorous exercise, intramuscular injections, or underlying immunosuppression may produce microscopic muscle injury, creating a favourable environment for bacterial seeding.

Once bacteria lodge within the injured muscle, they multiply and trigger an intense inflammatory response characterized by neutrophil infiltration, tissue oedema, and release of inflammatory mediators. During the early invasive stage, muscle fibres become swollen and inflamed but abscesses have not yet formed. As infection progresses, liquefactive necrosis develops, resulting in one or more intramuscular abscesses surrounded by inflamed muscle tissue. Without timely treatment, increasing tissue destruction may extend into adjacent fascial planes, leading to extensive muscle necrosis, compartment syndrome, bacteraemia, septic shock, and occasionally metastatic infections involving distant organs.

Risk factors

• HIV infection

• Diabetes mellitus

• Malnutrition

• Chronic kidney disease

• Malignancy

• Immunosuppressive therapy

• Corticosteroid use

• Minor muscle trauma

• Vigorous exercise

• Intramuscular injections

• Sickle cell disease

• Alcohol misuse

• Tropical residence or travel

Clinical presentation

Clinical manifestations vary according to the stage of disease.

Stage I (invasive stage)

• Fever

• Malaise

• Localized muscle pain

• Muscle tenderness

• Mild swelling

• Firm induration

• Reduced movement

Abscess formation is usually absent at this stage.

Stage II (suppurative stage)

• High-grade fever

• Severe localized pain

• Fluctuant swelling

• Warmth

• Erythema

• Intramuscular abscess

• Difficulty walking or using the affected limb

Large muscles commonly involved include:

• Quadriceps

• Gluteal muscles

• Iliopsoas

• Gastrocnemius

• Deltoid

Stage III (late stage)

• Septicemia

• Hypotension

• Tachycardia

• Extensive muscle necrosis

• Multiple abscesses

• Organ dysfunction

• Septic shock

Diagnostic criteria

Diagnosis is established using clinical features together with laboratory investigations and imaging.

Major criteria

• Imaging demonstrating intramuscular abscess or muscle inflammation

• Positive muscle biopsy or aspirated pus culture

• Intraoperative evidence of pyomyositis

Minor criteria

• Fever

• Localized muscle pain

• Tender swelling

• Fluctuation

• Elevated CRP

• Elevated ESR

• Leukocytosis

• Ultrasound or MRI findings consistent with pyomyositis

• Clinical response to antimicrobial therapy

Investigations

Laboratory investigations

• Complete blood count (CBC)

• Erythrocyte sedimentation rate (ESR)

• C-reactive protein (CRP)

• Blood cultures before antibiotic therapy where possible

• Renal and liver function tests in severe disease

Microbiological investigations

• Aspirated pus for Gram stain

• Culture and antimicrobial susceptibility testing

• Muscle biopsy for culture and sensitivity when required

Imaging

Ultrasound

• First-line investigation

• Detects intramuscular abscesses

• Guides aspiration and drainage

Plain X-ray

Usually normal but may exclude:

• Osteomyelitis

• Soft tissue gas

• Foreign bodies

MRI

Most sensitive investigation where available.

Demonstrates:

• Muscle oedema

• Abscess formation

• Extent of soft tissue involvement

• Adjacent osteomyelitis

CT scan

Useful when MRI is unavailable or for deep muscle infections.

Differential diagnosis

• Cellulitis

• Necrotizing fasciitis

• Osteomyelitis

• Septic arthritis

• Deep vein thrombosis

• Soft tissue sarcoma

• Intramuscular haematoma

• Muscle strain

Management

Successful treatment depends on:

• Early diagnosis

• Appropriate antimicrobial therapy

• Prompt drainage of abscesses

• Supportive care

• Management of underlying risk factors

Pharmacological treatment

Treatment at higher-level facilities should be guided by culture and antimicrobial susceptibility results.

Children

Cloxacillin

• IV every 6 hours for 7–14 days

OR

Erythromycin

• 500 mg orally every 6–8 hours for 7–14 days

OR

Vancomycin

• 1 g IV every 12 hours for 7 days

OR

Clindamycin

• 600 mg IV every 8 hours for 7 days

Adults

Erythromycin

• 500 mg orally every 6–8 hours for 7–14 days

OR

Amoxicillin + clavulanate (fixed-dose combination)

• 625 mg orally every 12 hours for 7–14 days

OR

Clindamycin

• 600 mg IV every 8 hours for 7 days

OR

Vancomycin

• 1 g IV every 12 hours for 7 days

Surgical management

Surgical drainage is indicated once an abscess has formed or when there is failure of conservative treatment.

Procedures include:

• Incision and drainage

• Thorough irrigation using copious amounts of 0.9% sodium chloride solution

• Debridement of necrotic muscle when necessary

• Repeat drainage for persistent or multiloculated abscesses

Supportive management

• Rest of the affected limb

• Adequate hydration

• Nutritional support

• Analgesics for pain control

• Antipyretics for fever

• Physiotherapy after the acute infection resolves

• Management of underlying conditions such as diabetes or HIV infection

Monitoring and follow-up

Patients should be monitored for:

• Resolution of fever

• Reduction in muscle pain and swelling

• Serial CRP and ESR

• White blood cell count

• Wound healing after drainage

• Repeat ultrasound if clinical improvement is delayed

• Adverse effects of antimicrobial therapy

Complications

• Intramuscular abscess

• Extensive muscle necrosis

• Compartment syndrome

• Osteomyelitis

• Septic arthritis

• Septicemia

• Septic shock

• Recurrent pyomyositis

• Chronic muscle fibrosis

• Functional disability

• Death

Prevention

• Prompt treatment of skin and soft tissue infections

• Good control of diabetes mellitus

• Early diagnosis and treatment of HIV infection

• Proper wound care

• Adequate nutrition

• Avoid unnecessary intramuscular injections

• Early treatment of bacteraemia

Patient education

Patients should be advised to:

• Complete the prescribed course of antibiotics.

• Attend all follow-up appointments.

• Seek immediate medical attention if fever, swelling, or pain worsens.

• Keep surgical wounds clean after drainage procedures.

• Participate in physiotherapy as advised.

• Maintain good control of chronic illnesses such as diabetes.

• Maintain adequate nutrition and hydration during recovery.

Prognosis

The prognosis is generally excellent when tropical pyomyositis is diagnosed during the invasive or early suppurative stage and treated promptly with appropriate antimicrobial therapy and surgical drainage when indicated. Delayed diagnosis increases the risk of extensive muscle necrosis, septicemia, recurrent infection, prolonged hospitalization, and permanent functional impairment. Patients with HIV infection, diabetes mellitus, severe malnutrition, or delayed presentation are at increased risk of complications and mortality.